Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis regulators.

Hisashi Harada1, Steven Grant

  • 1Department of Medicine, Virginia Commonwealth University, Medical College of Virginia, MCV Station, Box 230, Richmond, VA 23298, USA.

Reviews in Clinical and Experimental Hematology
|February 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The STEPs educational framework for medicines management: using mnemonics to reduce harm.

British journal of nursing (Mark Allen Publishing)·2026
Same author

Proteasome inhibition enhances lysosome-mediated targeted protein degradation.

Cell death & disease·2026
Same author

Sacituzumab Govitecan as an Effective Strategy for Sensitizing Chemoresistant HNSCC Cells to Senolytic Intervention.

bioRxiv : the preprint server for biology·2026
Same author

Dickkopf1 is a novel endogenous ligand for priming NLRP3 inflammasome in macrophages via TLR4.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer.

Frontiers in cell and developmental biology·2026
Same author

Assessing the Complexities of Utilizing BH3 Mimetics for a Senolytic Strategy in Combination with Ionizing Radiation.

Radiation research·2026
Same journal

Genomics in hematologic malignancies.

Reviews in clinical and experimental hematology·2006
Same journal

Infections in hematologic patients: the future.

Reviews in clinical and experimental hematology·2006
Same journal

Thrombotic problems in hematologic malignancies.

Reviews in clinical and experimental hematology·2006
Same journal

Prophylaxis and treatment of bacterial infections: do we need new strategies?

Reviews in clinical and experimental hematology·2006
Same journal

Recent developments in new and old viral infections.

Reviews in clinical and experimental hematology·2006
Same journal

Microbiologic consequences of new approaches to managing hematologic malignancies.

Reviews in clinical and experimental hematology·2006
See all related articles

Scientists are exploring apoptosis regulators, like BCL-2 family proteins, to understand cancer cell survival and develop new leukemia treatments. Targeting these pathways shows promise for enhancing cancer therapies.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Oncology

Background:

  • Apoptosis regulators govern survival in neoplastic cells, especially in hematopoietic cancers.
  • The BCL-2 family plays a crucial role in mitochondrial integrity and apoptosis.
  • Understanding these regulators is key to developing novel antileukemic strategies.

Purpose of the Study:

  • To elucidate the role of apoptosis regulators in neoplastic cell survival.
  • To investigate the BCL-2 family's function and its relation to mitochondrial integrity.
  • To explore the potential of modulating apoptotic pathways for cancer therapy.

Main Methods:

  • Classification of apoptosis regulators into mitochondrial function modulators and caspase activation regulators.
  • Investigation of the intrinsic (mitochondrial) and extrinsic (receptor-related) apoptotic pathways.

Related Experiment Videos

  • Analysis of cross-talk between apoptotic pathways and signal transduction pathways.

    • Main Results:

    • BCL-2 family proteins are categorized by their modulation of mitochondrial function or caspase activation.
    • Pro-apoptotic proteins (e.g., BAX, BAK) promote cytochrome C release, while anti-apoptotic proteins (e.g., BCL-2, BCL-xL) preserve mitochondrial integrity.
    • Small molecule inhibitors targeting BCL-2 or SMAC/DIABLO mimetics enhance antineoplastic activity.

    Conclusions:

    • Apoptosis regulation is critical for understanding neoplastic transformation.
    • Targeting apoptotic pathways offers potential for novel antileukemic therapies.
    • Modulating apoptosis regulators can improve the efficacy of conventional cytotoxic agents.